Longitudinal change in castration-resistant prostate cancer biomarker AST/ALT ratio reflects tumor progression
Abstract We investigated whether aspartate transaminase (AST)-to-alanine aminotransferase (ALT) ratio and its change during the course of treatment in castration-resistant prostate cancer (CRPC) patients is associated with tumor condition and lethality. Clinical data from 130 CRPC patients were retr...
Main Authors: | Yozo Mitsui, Fumito Yamabe, Shunsuke Hori, Masato Uetani, Hiroshi Aoki, Kei Sakurabayashi, Mizuho Okawa, Hideyuki Kobayashi, Koichi Nagao, Koichi Nakajima |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-42711-z |
Similar Items
-
Combination of C-reactive protein/albumin ratio and time to castration resistance enhances prediction of prognosis for patients with metastatic castration-resistant prostate cancer
by: Yozo Mitsui, et al.
Published: (2023-06-01) -
Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie’s Disease
by: Yozo Mitsui, et al.
Published: (2023-06-01) -
Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke
by: Mona Asghari Ahmadabad, et al.
Published: (2022-12-01) -
Prognostic Value of the AST/ALT Ratio versus Bilirubin in Patients with Cardiogenic Shock
by: Tobias Schupp, et al.
Published: (2023-08-01) -
Cambios Séricos en las Enzimas Alt, Ast, Fa, Ck-Total
by: José , Noriega-Alvarado, et al.
Published: (2009-07-01)